Urinary cannabinoid levels during nabiximols (Sativex®)-medicated inpatient cannabis withdrawal.

Distribution Theory for Glass's Estimator of Effect Size and Related Estimators

Hedges, L. V. (1981) · Journal of Educational Statistics · doi:10.2307/1164588 · Cited by 5,695 · see citing works

Validation of new methods

Peters, F. T., Drummer, O. H., & Mußhoff, F. (2006) · Forensic Science International · doi:10.1016/j.forsciint.2006.05.021 · Cited by 1,347 · see citing works

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059 · see citing works

Cannabidiol is a negative allosteric modulator of the cannabinoid CB ₁ receptor

Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039 · see citing works

Cannabidiol as a Potential Treatment for Anxiety Disorders

Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 717 · see citing works

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex^®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis: Sativex for refractory spasticity in MS

Novotna, A., Mares, J., Ratcliffe, S., Novakova, I., Vachova, M., Zapletalova, O., Gasperini, C., Pozzilli, C., Cefaro, L., Comi, G., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03328.x · Cited by 475 · see citing works

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.519 · Cited by 465 · see citing works

Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability

Iannotti, F. A., Hill, C. L., Leo, A., Alhusaini, A. M., Soubrane, C., Mazzarella, E., Russo, E., Whalley, B. J., Marzo, V. D., & Stephens, G. J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000524 · Cited by 414 · see citing works

The cannabis withdrawal syndrome

Budney, A. J., & Hughes, J. R. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000218592.00689.e5 · Cited by 351 · see citing works

Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review

Stout, S. M., & Cimino, N. M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.849268 · Cited by 350 · see citing works

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

Morgan, C. J. A., Schafer, G., Freeman, T. P., & Curran, H. V. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.077503 · Cited by 305 · see citing works

The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study

Degenhardt, L. J., Ferrari, A. J., Calabria, B., Hall, W., Norman, R. E., McGrath, J. J., Flaxman, A. D., Engell, R. E., Freedman, G., Whiteford, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076635 · Cited by 296 · see citing works

Practical and statistical issues in missing data for longitudinal patient-reported outcomes

Bell, M. L., & Fairclough, D. L. (2013) · Statistical Methods in Medical Research · doi:10.1177/0962280213476378 · Cited by 285 · see citing works

Cannabinoids and Epilepsy

Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0375-5 · Cited by 282 · see citing works

Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial

Allsop, D. J., Copeland, J., Lintzeris, N., Dunlop, A. J., Montebello, M., Sadler, C., Rivas, G. R., Holland, R. M., Muhleisen, P., Norberg, M. M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3947 · Cited by 266 · see citing works

Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease

O’Sullivan, S. E., & Kendall, D. A. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.09.007 · Cited by 247 · see citing works

Cannabinoids in the Treatment of Epilepsy

Friedman, D. J., & Devinsky, O. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1407304 · Cited by 243 · see citing works

Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes

Watanabe, K., Yamaori, S., Funahashi, T., Kimura, T., & Yamamoto, I. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.12.032 · Cited by 237 · see citing works

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

Waldo Zuardi, A., Alexandre S. Crippa, J., E.C. Hallak, J., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., K. McGuire, P., & Silveira Guimaraes, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884681 · Cited by 222 · see citing works

The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress

Allsop, D. J., Norberg, M. M., Copeland, J., Fu, S., & Budney, A. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.003 · Cited by 206 · see citing works

Pharmacokinetics of Cannabinoids

McGilveray, I. J. (2005) · Pain Research and Management · doi:10.1155/2005/242516 · Cited by 203 · see citing works

Comparison of cannabis and tobacco withdrawal: Severity and contribution to relapse

Budney, A. J., Vandrey, R. G., Hughes, J. R., Thostenson, J. D., & Bursac, Z. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2008.01.002 · Cited by 195 · see citing works

Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile

Swift, W., Wong, A. C. H., Li, K. M., Arnold, J. C., & McGregor, I. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070052 · Cited by 182 · see citing works

Delta-9-Tetrahydrocannabinol: Metabolism and Disposition in Long-Term Marihuana Smokers

Lemberger, L., Tamarkin, N. R., Axelrod, J., & Kopin, I. J. (1971) · Science · doi:10.1126/science.173.3991.72 · Cited by 180 · see citing works

Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms

Budney, A. J., Vandrey, R. G., Hughes, J. R., Moore, B. A., & Bahrenburg, B. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.014 · Cited by 180 · see citing works

Quantifying the Clinical Significance of Cannabis Withdrawal

Allsop, D. J., Copeland, J., Norberg, M. M., Fu, S., Molnár, A. B., Lewis, J., & Budney, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044864 · Cited by 179 · see citing works

Pharmacotherapies for cannabis dependence.

Marshall, K., Gowing, L., Ali, R., & Le Foll, B. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub2 · Cited by 156 · see citing works

Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids

Mazur, A., Lichti, C. F., Prather, P. L., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026898 · Cited by 155 · see citing works

Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws

Bergamaschi, M. M., Karschner, E. L., Goodwin, R. S., Scheidweiler, K. B., Hirvonen, J., Queiróz, R. H. C., & Huestis, M. A. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.195503 · Cited by 154 · see citing works

Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers

Levin, K. H., Copersino, M. L., Heishman, S. J., Liu, F., Kelly, D. L., Boggs, D. L., & Gorelick, D. A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.04.010 · Cited by 150 · see citing works

Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent Smokers Following Controlled Smoked Cannabis

Desrosiers, N. A., Himes, S. K., Scheidweiler, K. B., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.216507 · Cited by 145 · see citing works

Determination of Δ1‐tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography–mass spectrometry

Johansson, E., Norén, K., Sjövall, J., & Halldin, M. M. (1989) · Biomedical Chromatography · doi:10.1002/bmc.1130030109 · Cited by 136 · see citing works

Cannabidiol enhances microglial phagocytosis via transient receptor potential ( TRP ) channel activation

Hassan, S., Eldeeb, K., Millns, P. J., Bennett, A. J., Alexander, S. P. H., & Kendall, D. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12615 · Cited by 135 · see citing works

Bupropion SR worsens mood during marijuana withdrawal in humans

Haney, M., Ward, A. S., Comer, S. D., Hart, C. L., Foltin, R. W., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130000657 · Cited by 135 · see citing works

Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse

Haney, M., Cooper, Z. D., Bedi, G., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.54 · Cited by 132 · see citing works

Cannabinoids and Multiple Sclerosis

Pertwee, R. G. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0005-2 · Cited by 113 · see citing works

Identification in human urine of Δ9-tetrahydrocannabinol-11-oic acid glucuronide: a tetrahydrocannabinol metabolite

Williams, P. L., & Moffat, A. C. (1980) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1980.tb12966.x · Cited by 109 · see citing works

Metabolites of cannabidiol identified in human urine

Harvey, D. J., & Mechoulam, R. (1990) · Xenobiotica · doi:10.3109/00498259009046849 · Cited by 98 · see citing works

Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.

Trigo, J. M., Lagzdins, D., Rehm, J., Selby, P., Gamaleddin, I., Fischer, B., Barnes, A. J., Huestis, M. A., & Le Foll, B. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.020 · Cited by 97 · see citing works

Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts

Grauwiler, S. B., Scholer, A., & Drewe, J. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.12.045 · Cited by 93 · see citing works

Heterogeneity in the composition of marijuana seized in California

Burgdorf, J. R., Kilmer, B., & Pacula, R. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.031 · Cited by 81 · see citing works

Urinary Excretion Half-Life of 11-Nor-9-carboxy-Δ9-tetrahydrocannabinol in Humans

Huestis, M. A., & Cone, E. J. (1998) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199810000-00021 · Cited by 79 · see citing works

Cannabinoid abuse and addiction: Clinical and preclinical findings

Panlilio, L. V., Goldberg, S. R., & Justinová, Z. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.118 · Cited by 74 · see citing works

Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry

Scheidweiler, K. B., Desrosiers, N. A., & Huestis, M. A. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.06.034 · Cited by 73 · see citing works

Novel Pharmacologic Approaches to Treating Cannabis Use Disorder

Balter, R. E., Cooper, Z. D., & Haney, M. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0011-1 · Cited by 54 · see citing works

First systematic evaluation of the potency of Cannabis sativa plants grown in Albania

Bruci, Z., Papoutsis, I. I., Athanaselis, S., Nikolaou, P., Pazari, E., Spiliopoulou, C., & Vyshka, G. (2012) · Forensic Science International · doi:10.1016/j.forsciint.2012.04.032 · Cited by 54 · see citing works

Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal

Allsop, D. J., Lintzeris, N., Copeland, J., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.109 · Cited by 44 · see citing works

Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine

Bergamaschi, M. M., Barnes, A. J., Queiróz, R. H. C., Hurd, Y. L., & Huestis, M. A. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-6837-x · Cited by 43 · see citing works

Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

Lee, D., Karschner, E. L., Milman, G., Barnes, A. J., Goodwin, R. S., & Huestis, M. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.10.011 · Cited by 29 · see citing works

A survey of the potency of Japanese illicit cannabis in fiscal year 2010

Tsumura, Y., Aoki, R., Tokieda, Y., Akutsu, M., Kawase, Y., Kataoka, T., Takagi, T., Mizuno, T., Fukada, M., Fujii, H., et al. (2012) · Forensic Science International · doi:10.1016/j.forsciint.2012.04.005 · Cited by 28 · see citing works

Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences

Wong, A., Keats, K., Rooney, K. B., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3532-3 · Cited by 12 · see citing works

Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis

Scott, J. C., Slomiak, S. T., Jones, J. D., Rosen, A. F. G., Moore, T. M., & Gur, R. C. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0335 · Cited by 391 · see citing works

Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines – Identification of potential distinguishing markers

Scheunemann, A., Elsner, K., Germerott, T., Hess, C., Zörntlein, S., & Röhrich, J. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110773 · Cited by 11 · see citing works

Identification of Potential Distinguishing Markers for the Use of Cannabis-Based Medicines or Street Cannabis in Serum Samples

Scheunemann, A., Elsner, K., Germerott, T., Groppa, S., Heß, C., Miederer, I., Poplawski, A., & Röhrich, J. (2021) · Metabolites · doi:10.3390/metabo11050316 · Cited by 9 · see citing works

Cannabinoid bis-homologues: Miniaturised synthesis and GLC study

Crombie, L., & Crombie, W. M. L. (1975) · Phytochemistry · doi:10.1016/0031-9422(75)85042-4 · Cited by 15 · see citing works

Potency trends of Δ9‐tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005–15

Niesink, R. J. M., Rigter, S., Koeter, M. W. J., & Brunt, T. M. (2015) · Addiction · doi:10.1111/add.13082 · Cited by 94 · see citing works

Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis

Milman, G., Schwope, D. M., Gorelick, D. A., & Huestis, M. A. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.01.011 · Cited by 61 · see citing works